| Sub Cat | Epitope | Isotype | Application | Affinity | |
|---|---|---|---|---|---|
| V3S-1124-YC437 | IgG | WB; Neut; FuncS | |||
| V3S-0522-YC7780 | IgG1 lambda | Neut | |||
| V3S-0522-YC897 | IgG1 | ELISA; Neut | |||
| V3S-0723-FY157 | In the aa 180-195. | IgM | ELISA; WB; Neut | 199 nM to PR8/A/34 virus HA 130 nM to Hokaido virus HA |
|
| V3S-0522-YC958 | IgG1 kappa | Neut | |||
| V3S-0723-FY156 | IgG | ELISA; WB; Neut | |||
| V3S-1022-YC1799 | In the stem region of hemagglutinin, that is in a portion between regions HA1 and HA2. The residues critical for the binding which were identified are the following: W357 and T358 on region HA2; N336; 1337; P338 on region HA1. | IgG | WB; ELISA; IF; Neut | ||
| V3S-1022-YC20 | IgG | Neut | 550 pM | ||
| V3S-1022-YC517 | IgG | Neut | 90 pM | ||
| V3S-1022-YC725 | IgG | Neut | |||
| V3S-1022-YC726 | IgG | Neut | |||
| V3S-0622-YC3429 | Located in aa 234-241 of IAV HA. | IgG | ELISA; IHC | ||
| V3S-0522-YC7441 | IgG1 kappa | WB; ELISA; FuncS | |||
| V3S-0522-YC7444 | IgG lambda | WB; ELISA; FuncS | |||
| V3S-0522-YC7445 | IgG | WB; ELISA; FuncS | |||
| V3S-0522-YC7459 | IgG | WB; IHC; FuncS | |||
| V3S-0522-YC821 | IgG | ELISA | |||
| V3S-0622-YC3428 | IgG | ELISA; IHC | |||
| V3S-0622-YC3435 | IgG | ELISA; FC | |||
| V3S-0622-YC3436 | IgG | ELISA; FC | |||
| V3S-0622-YC3563 | IgG | ELISA | |||
| V3S-1022-YC106 | IgG1 | Activ | |||
| V3S-1022-YC1469 | IgG | ELISA; Activ | |||
| V3S-1022-YC1470 | IgG | ELISA; ELISPOT; IHC; Activ | |||
| V3S-1022-YC2213 | In the stem region of HA. | IgG | WB; ELISA; FC; IF | ||
| V3S-1022-YC73 | IgG | ELISA; WB |
| Description | This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Influenza A virus hemagglutinin. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Influenza A virus (IAV) |
| Immunogen | Influenza a virus Hemagglutinin |
| Isotype | IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | WB; Neut; FuncS |
| Application Notes | The antibody is recommended for detection of IAV HA by WB, Neut, FuncS assays. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | IAV HA |
| Alternative Name | HA; hemagglutinin; haemagglutinin |
| Research Area | Microbiology; Infectious Disease |
